<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>immunology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>immunology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="In silico assessment of immune cross protection between BCoV and SARS-CoV-2
Authors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.
Score: 162.8, Published: 2024-01-26 DOI: 10.1101/2024.01.25.577193
BackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/immunology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="immunology" />
<meta property="og:description" content="In silico assessment of immune cross protection between BCoV and SARS-CoV-2
Authors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.
Score: 162.8, Published: 2024-01-26 DOI: 10.1101/2024.01.25.577193
BackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/immunology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-31T10:38:28+00:00" />
<meta property="article:modified_time" content="2024-01-31T10:38:28+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="immunology"/>
<meta name="twitter:description" content="In silico assessment of immune cross protection between BCoV and SARS-CoV-2
Authors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.
Score: 162.8, Published: 2024-01-26 DOI: 10.1101/2024.01.25.577193
BackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "immunology",
      "item": "https://trxiv.yorks0n.com/posts/immunology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "immunology",
  "name": "immunology",
  "description": "In silico assessment of immune cross protection between BCoV and SARS-CoV-2\nAuthors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.\nScore: 162.8, Published: 2024-01-26 DOI: 10.1101/2024.01.25.577193\nBackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions.",
  "keywords": [
    
  ],
  "articleBody": " In silico assessment of immune cross protection between BCoV and SARS-CoV-2\nAuthors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.\nScore: 162.8, Published: 2024-01-26 DOI: 10.1101/2024.01.25.577193\nBackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions. Since BCoVs are phylogenetically close to SARS-CoV-2, it is possible that cross-protection against COVID-19 occurs in people exposed to BCoV. MethodsThis article shows an in silico investigation of human cross-protection to SARS-CoV-2 due to BCoV exposure. We determined HLA recognition and human B lymphocyte reactivity to BCoV epitopes using bioinformatics resources. A retrospective geoepidemiological analysis of COVID-19 was then performed to verify if BCoV/SARS-CoV-2 cross-protection could have occurred in the field. Brazil was used as a model for the epidemiological analysis of the impact of livestock density - as a proxy for human exposure to BCoV - on the prevalence of COVID-19 in people. ResultsAs could be expected from their classification in the same Betacoronavirus genus, we show that several human B and T epitopes are shared between BCoV and SARS-CoV-2. This raised the possibility of cross-protection of people from exposure to the bovine coronavirus. Analysis of field data added partial support to the hypothesis of viral cross-immunity from human exposure to BCoV. There was a negative correlation between livestock geographical density and COVID-19. Whole-Brazil data showed areas in the country in which COVID-19 prevalence was disproportionally low (controlled by normalization by transport infrastructure). Areas with high cattle density had lower COVID-19 prevalence in these low-risk areas. ConclusionsThese data are hypothesis-raising indications that cross-protection is possibly being induced by human exposure to the Bovine Coronavirus.\nHybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination\nAuthors: Voss, W. N.; Mallory, M. A.; Byrne, P. O.; Marchioni, J. M.; Knudson, S. A.; Powers, J. M.; Leist, S. R.; Dadonaite, B.; Townsend, D. R.; Kain, J.; Huang, Y.; Satterwhite, E.; Castillo, I. N.; Mattocks, M.; Paresi, C.; Munt, J. E.; Scobey, T.; Seeger, A.; Premkumar, L.; Bloom, J. D.; Georgiou, G.; McLellan, J. S.; Baric, R. S.; Lavinder, J. J.; Ippolito, G. C.\nScore: 80.4, Published: 2024-01-23 DOI: 10.1101/2024.01.22.576742\nWe used plasma IgG proteomics to study the molecular composition and temporal durability of polyclonal IgG antibodies triggered by ancestral SARS-CoV-2 infection, vaccination, or their combination (\"hybrid immunity\"). Infection, whether primary or post-vaccination, mainly triggered an anti-spike antibody response to the S2 domain, while vaccination predominantly induced anti-RBD antibodies. Immunological imprinting persisted after a secondary (hybrid) exposure, with \u003e60% of the ensuing serological response originating from the initial antibodies generated during the first exposure. We highlight one instance where hybrid immunity arising from breakthrough infection resulted in a marked increase in the breadth and affinity of a highly abundant vaccination-elicited plasma IgG antibody, SC27. With an intrinsic binding affinity surpassing a theoretical maximum (KD \u003c 5 pM), SC27 demonstrated potent neutralization of various SARS-CoV-2 variants and SARS-like zoonotic viruses (IC50 [~]0.1-1.75 nM) and provided robust protection in vivo. Cryo-EM structural analysis unveiled that SC27 binds to the RBD class 1/4 epitope, with both VH and VL significantly contributing to the binding interface. These findings suggest that exceptionally broad and potent antibodies can be prevalent in plasma and can largely dictate the nature of serological neutralization. HIGHLIGHTS{blacksquare} Infection and vaccination elicit unique IgG antibody profiles at the molecular level {blacksquare}Immunological imprinting varies between infection (S2/NTD) and vaccination (RBD) {blacksquare}Hybrid immunity maintains the imprint of first infection or first vaccination {blacksquare}Hybrid immune IgG plasma mAbs have superior neutralization potency and breadth\nCD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment\nAuthors: Kar, M.; Johnson, K. E. E.; Vanderheiden, A.; Elrod, E. J.; Floyd, K.; Geerling, E.; Stone, E. T.; Salinas, E.; Banakis, S.; Wang, W.; Sathish, S.; Shrihari, S.; Davis-Gardner, M. E.; Kohlmeier, J.; Pinto, A.; Klein, R.; Grakoui, A.; Ghedin, E.; Suthar, M. S.\nScore: 66.9, Published: 2024-01-24 DOI: 10.1101/2024.01.23.576505\nSARS-CoV-2 is the causative agent of COVID-19 and continues to pose a significant public health threat throughout the world. Following SARS-CoV-2 infection, virus-specific CD4+ and CD8+ T cells are rapidly generated to form effector and memory cells and persist in the blood for several months. However, the contribution of T cells in controlling SARS-CoV-2 infection within the respiratory tract are not well understood. Using C57BL/6 mice infected with a naturally occurring SARS-CoV-2 variant (B.1.351), we evaluated the role of T cells in the upper and lower respiratory tract. Following infection, SARS-CoV-2-specific CD4+ and CD8+ T cells are recruited to the respiratory tract and a vast proportion secrete the cytotoxic molecule Granzyme B. Using antibodies to deplete T cells prior to infection, we found that CD4+ and CD8+ T cells play distinct roles in the upper and lower respiratory tract. In the lungs, T cells play a minimal role in viral control with viral clearance occurring in the absence of both CD4+ and CD8+ T cells through 28 days post-infection. In the nasal compartment, depletion of both CD4+ and CD8+ T cells, but not individually, results in persistent and culturable virus replicating in the nasal compartment through 28 days post-infection. Using in situ hybridization, we found that SARS-CoV-2 infection persisted in the nasal epithelial layer of tandem CD4+ and CD8+ T cell-depleted mice. Sequence analysis of virus isolates from persistently infected mice revealed mutations spanning across the genome, including a deletion in ORF6. Overall, our findings highlight the importance of T cells in controlling virus replication within the respiratory tract during SARS-CoV-2 infection.\nDevelopment of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune Diseases\nAuthors: Anaya, D.; Kwong, B.; Park, S.; Biswas, S.; Jeevan, J.; Strobach, M.; Khoshnoodi, N.; Register, A.; Klasson, T.; Foos-Russ, S.; Zeng, J.; Banuelos, J.; Gibson, C.; Bravo, J.; Flandez, J.; Van Blarcom, T.; Walker, K.\nScore: 57.4, Published: 2024-01-24 DOI: 10.1101/2024.01.24.576713\nApheresis, a conventional starting point for manufacturing chimeric antigen receptor (CAR) T-cell therapy, poses challenges due to the length and invasiveness of the procedure, the high demand for and limited quantity of apheresis beds, and additional resource constraints at collection centers. Furthermore, traditional CAR T-cell manufacturing often involves extended cell culture periods, leading to a final product that has progressed through the differentiation process and contains a higher frequency of cells with phenotypes that are indicative of lower functionality or potency.1 Here, we show that anti-CD19 CAR T-cells manufactured from fresh whole blood with minimal ex vivo expansion using Ingenui-T exhibit comparable or superior CAR-mediated and CD19-dependent functional activity compared to CAR T-cells manufactured from cryopreserved leukapheresis material following the a conventional manufacturing process. Anti-CD19 CAR T-cell production, manufactured from whole blood in less than 3 days of in vitro culture using Ingenui-T, yielded an average of about 40 million cells per 100 mL with high CD3 purity and viability. Furthermore, the final product was composed of cells with less differentiated phenotypes and sustained cytotoxic activity against CD19+ target cells at a lower dose than conventionally manufactured CAR T cells in preclinical in vitro assays. Ingenui-T is an innovative vein-to-vein solution, aimed at enhancing the patient experience, feasibility, and accessibility of CAR T-cell therapy by alleviating challenges linked to apheresis-based methods, with its patient-friendly nature, cost-effectiveness, and distinctive methodology.\nFull resolution HLA and KIR genes annotation for human genome assemblies\nAuthors: Zhou, Y.; Song, L.; Li, H.\nScore: 42.7, Published: 2024-01-23 DOI: 10.1101/2024.01.20.576452\nThe HLA (Human Leukocyte Antigen) genes and the KIR (Killer cell Immunoglobulin-like Receptor) genes are critical to immune responses and are associated with many immune-related diseases. Located in highly polymorphic regions, they are hard to be studied with traditional short-read alignment-based methods. Although modern long-read assemblers can often assemble these genes, using existing tools to annotate HLA and KIR genes in these assemblies remains a non-trivial task. Here, we describe Immuannot, a new computation tool to annotate the gene structures of HLA and KIR genes and to type the allele of each gene. Applying Immuannot to 56 regional and 212 whole-genome assemblies from previous studies, we annotated 9,931 HLA and KIR genes and found that almost half of these genes, 4,068, had novel sequences compared to the current Immuno Polymorphism Database (IPD). These novel gene sequences were represented by 2,664 distinct alleles, some of which contained non-synonymous variations resulting in 92 novel protein sequences. We demonstrated the complex haplotype structures at the two loci and reported the linkage between HLA/KIR haplotypes and gene alleles. We anticipate that Immuannot will speed up the discovery of new HLA/KIR alleles and enable the association of HLA/KIR haplotype structures with clinical outcomes in the future.\nCytotoxic CD4+ T cells in the bone marrow compromise healthy ageing by enhancing granulopoiesis\nAuthors: Gabande-Rodriguez, E.; Soto-Heredero, G.; Carrasco, E.; Anerillas, C.; Escrig-Larena, J. I.; Delgado-Pulido, S.; Francos-Quijorna, I.; Gomez de las Heras, M. M.; Fernandez-Almeida, A.; Blanco, E. M.; Winand-Osete, E.; Zorita, V.; Martinez-Cano, J.; Garrido, A.; de Cabo, R.; Manes, S.; Gorospe, M.; Mittelbrunn, M.\nScore: 34.7, Published: 2024-01-29 DOI: 10.1101/2024.01.26.577360\nNeutrophils are the most abundant leukocytes in the blood, with numbers further increasing with age. Despite their essential role as a primary line of defense, neutrophils can contribute to tissue damage and age-related diseases and a high neutrophil-to lymphocyte ratio predicts all causes of mortality in the elderly. However, the precise mechanisms driving enhanced neutrophil generation during ageing remain poorly understood. Here, we show that a subset of CD4+ T cells with a cytotoxic phenotype (CD4+ CTLs) producing the chemokine CCL5 and harbouring dysfunctional mitochondria, infiltrate the bone marrow and induce granulopoiesis in aged mice. During ageing, hematopoietic stem cells upregulate CCR5, the primary receptor for CCL5, and its deficiency limits the T cell-mediated induction of granulopoiesis and neutrophil output. Treatment with the FDA-approved CCR5 inhibitor Maraviroc decreases granulopoiesis and lowers the levels of circulatory and tissue-infiltrating neutrophils, ameliorating multiple ageing biomarkers and improving functional outcomes in aged mice. These findings suggest that age-associated alterations in T cells reduce health outcomes by remodelling the bone marrow niche and enhancing neutrophil generation. Consequently, interventions to disrupt the interplay between T cells and haematopoietic stem cells hold substantial therapeutic potential to ameliorate age-associated diseases.\nCD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging\nAuthors: Elyahu, Y.; Feygin, I.; Pinkas, N.; Zemer, A.; Shicht, A.; Berner, O.; Eremenko, E.; Nemirovsky, A.; Reshef, K.; Roitman, L.; Krizhanovsky, V.; Monsonego, A.\nScore: 22.2, Published: 2024-01-15 DOI: 10.1101/2024.01.14.575313\nAging is characterized by the progressive deterioration of tissue structure and function, leading to increased vulnerability to diseases and, eventually, death. One prominent process in aging is the accumulation of senescent cells. Although the immune system has been recognized as crucial for the elimination of senescent cells, the associated mechanisms remain incompletely understood. Here we show that CD4 T cells differentiate into cytotoxic T lymphocytes (CTLs) in a senescent cell-rich environment and that a reduction in the senescent cell load, achieved using chemical senolytic drugs, was sufficient to halt this differentiation. We further demonstrate that eliminating CD4 CTLs in the context of late aging by selectively deleting the Eomes transcription factor in CD4 T cells resulted in the increased accumulation of senescent cells, profound physical deterioration, and a decreased life span. In liver cirrhosis, a model of localized chronic inflammation, CD4 CTL elimination increased the senescent load and worsened the disease. Collectively, our findings demonstrate the fundamental role of CD4 CTLs in modulating tissue senescence and unveil a new aspect of age-related T-cell biology implicated in disease susceptibility and longevity.\nRegulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells\nAuthors: Costa-Pereira, S.; Lanzinger, M.; Andreadou, M.; Nunez, N.; Villar-Vesga, J.; Prisco, F.; Hane, P.; Roussel, E.; Krishnarajah, S.; Lindemann, R. C.; Westermann, F.; Oberbichler, L.; Sethi, A.; Fonseca, A.; Pinzger, M.; Tugues, S.; Mundt, S.; Kipar, A.; Greter, M.; De Feo, D.; Becher, B.\nScore: 14.9, Published: 2024-01-27 DOI: 10.1101/2024.01.24.577048\nRegulatory T (Treg) cells are critical for maintaining peripheral tolerance and preventing autoimmunity. Treg cell depletion or dysfunction rapidly results in fatal multiorgan inflammation linked to unrestrained effector T cell expansion, but the cytokine network underlying immunopathology, and its direct cellular mediators, remain elusive. Here, we combined gene targeting, fate-mapping tools, and high-dimensional cytometry to identify the T helper (TH) cell-derived cytokines and responding cells that execute inflammatory tissue damage upon global loss of peripheral tolerance in mice. We found that TH cell-derived GM-CSF, but not IL-17A, directed the ensuing immunopathology and thereby mortality through recruitment of tissue-invading phagocytes and granulocytes, and enhancement of their reactive oxygen species production and phagocytic proficiency. Our study highlights the critical role of Treg cells in controlling GM-CSF- producing TH cells and type 1-responses to restrain phagocyte-mediated tissue destruction and provides a framework for the use of anti-GM-CSF therapies in patients with chronic inflammatory disorders.\nLearning predictive signatures of HLA type from T-cell repertoires\nAuthors: Ortega, M. R.; Pogorelyy, M.; Minervina, A.; Thomas, P.; Walczak, A.; Mora, T.\nScore: 12.9, Published: 2024-01-29 DOI: 10.1101/2024.01.25.577228\nT cells recognize a wide range of pathogens using surface receptors that interact directly with peptides presented on major histocompatibility complexes (MHC) encoded by the HLA loci in humans. Understanding the association between T cell receptors (TCR) and HLA alleles is an important step towards predicting TCR-antigen specificity from sequences. Here we analyze the TCR alpha and beta repertoires of large cohorts of HLA-typed donors to systematically infer such associations, by looking for overrepresentation of TCRs in individuals with a common allele.TCRs, associated with a specific HLA allele, exhibit sequence similarities that suggest prior antigen exposure. Immune repertoire sequencing has produced large numbers of datasets, however the HLA type of the corresponding donors is rarely available. Using our TCR-HLA associations, we trained a computational model to predict the HLA type of individuals from their TCR repertoire alone. We propose an iterative procedure to refine this model by using data from large cohorts of untyped individuals, by recursively typing them using the model itself. The resulting model shows good predictive performance, even for relatively rare HLA alleles.\nIntegrative single-cell multi-omics of CD19CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias\nAuthors: Guerrero-Murillo, M.; Rill-Hinarejos, A.; Trincado, J. L.; Bataller, A.; Ortiz-Maldonado, V.; Benitez-Ribas, D.; Espanol, M.; Gonzalez, E. A.; Martinez-Cibrian, N.; Marchese, D.; Martin-Martin, L.; Garcia-Sancho, A. M.; Heyn, H.; Juan, M.; Urbano-Ispizua, A.; Delgado, J.; Orfao, A.; Mereu, E.; Bueno, C.; Menendez, P.\nScore: 10.6, Published: 2024-01-26 DOI: 10.1101/2024.01.23.576878\nHow phenotypic, clonal, and functional heterogeneity of CAR-T-cells impact clinical outcomes remain understudied. Here, we integrated clonal kinetics with transcriptomic heterogeneity resolved by single-cell omics to explore cellular dynamics response of both non-transduced (CARneg) and transduced (CARpos)T-cells. CARneg and CARposT-cells were longitudinally interrogated in the manufactured infusion product (IP) and in-vivo at CAR-T cell expansion peak in five B-ALL patients treated with CD19CAR-T-cells (varni-cel). Significant differences were found in the cellular dynamics between CARpos and CARnegT-cells in response to therapy. CARposT-cells in the IP exhibited a significant higher CD4:CD8 ratio than CARnegT-cells, and the CD4:CD8 CARposT-cell composition impacted therapy outcome as confirmed in a larger cohort of 24 varni-cel-treated B-ALL patients. Conversely, an inverted trend in the CD4:CD8 CARposT-cell ratio was consistently observed at the expansion peak, with clonally expanding CD8+ effector memory and cytotoxic T-cells being the most abundant populations. Expanded cytotoxic CARpos{gamma}{delta}T cells emerged at the expansion peak, and the extent of their in-vivo expansion positively correlated with treatment efficacy, which was validated in a large cohort of B-ALL patients (n=18) treated with varni-cell and B-cell lymphoma patients (n=58) treated with either lisa-cel or axi-cel. Our data provide insights into the complexity and diversity of T-cell responses following CAR-T cell therapy and suggest drivers of immunotherapy response.\n",
  "wordCount" : "2646",
  "inLanguage": "en",
  "datePublished": "2024-01-31T10:38:28Z",
  "dateModified": "2024-01-31T10:38:28Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/immunology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      immunology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 31, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.25.577193">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.25.577193" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.25.577193">
        <p class="paperTitle">In silico assessment of immune cross protection between BCoV and SARS-CoV-2</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.25.577193" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.25.577193" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Beirao, B. C. B.; Querne, L. B.; Zettel Bastos, F.; Adur, M. d. A.; Cavalheiro, V. L.</p>
        <p class="info">Score: 162.8, Published: 2024-01-26 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.25.577193' target='https://doi.org/10.1101/2024.01.25.577193'> 10.1101/2024.01.25.577193</a></p>
        <p class="abstract">BackgroundHumans have long shared infectious agents with cattle, and the bovine-derived human common cold OC-43 CoV is a not-so-distant example of cross-species viral spill over of coronaviruses. Human exposure to the Bovine Coronavirus (BCoV) is certainly common, as the virus is endemic in most high-density cattle-raising regions. Since BCoVs are phylogenetically close to SARS-CoV-2, it is possible that cross-protection against COVID-19 occurs in people exposed to BCoV.

MethodsThis article shows an in silico investigation of human cross-protection to SARS-CoV-2 due to BCoV exposure. We determined HLA recognition and human B lymphocyte reactivity to BCoV epitopes using bioinformatics resources. A retrospective geoepidemiological analysis of COVID-19 was then performed to verify if BCoV/SARS-CoV-2 cross-protection could have occurred in the field. Brazil was used as a model for the epidemiological analysis of the impact of livestock density - as a proxy for human exposure to BCoV - on the prevalence of COVID-19 in people.

ResultsAs could be expected from their classification in the same Betacoronavirus genus, we show that several human B and T epitopes are shared between BCoV and SARS-CoV-2. This raised the possibility of cross-protection of people from exposure to the bovine coronavirus. Analysis of field data added partial support to the hypothesis of viral cross-immunity from human exposure to BCoV. There was a negative correlation between livestock geographical density and COVID-19. Whole-Brazil data showed areas in the country in which COVID-19 prevalence was disproportionally low (controlled by normalization by transport infrastructure). Areas with high cattle density had lower COVID-19 prevalence in these low-risk areas.

ConclusionsThese data are hypothesis-raising indications that cross-protection is possibly being induced by human exposure to the Bovine Coronavirus.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.22.576742">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.22.576742" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.22.576742">
        <p class="paperTitle">Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.22.576742" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.22.576742" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Voss, W. N.; Mallory, M. A.; Byrne, P. O.; Marchioni, J. M.; Knudson, S. A.; Powers, J. M.; Leist, S. R.; Dadonaite, B.; Townsend, D. R.; Kain, J.; Huang, Y.; Satterwhite, E.; Castillo, I. N.; Mattocks, M.; Paresi, C.; Munt, J. E.; Scobey, T.; Seeger, A.; Premkumar, L.; Bloom, J. D.; Georgiou, G.; McLellan, J. S.; Baric, R. S.; Lavinder, J. J.; Ippolito, G. C.</p>
        <p class="info">Score: 80.4, Published: 2024-01-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.22.576742' target='https://doi.org/10.1101/2024.01.22.576742'> 10.1101/2024.01.22.576742</a></p>
        <p class="abstract">We used plasma IgG proteomics to study the molecular composition and temporal durability of polyclonal IgG antibodies triggered by ancestral SARS-CoV-2 infection, vaccination, or their combination (&#34;hybrid immunity&#34;). Infection, whether primary or post-vaccination, mainly triggered an anti-spike antibody response to the S2 domain, while vaccination predominantly induced anti-RBD antibodies. Immunological imprinting persisted after a secondary (hybrid) exposure, with &gt;60% of the ensuing serological response originating from the initial antibodies generated during the first exposure. We highlight one instance where hybrid immunity arising from breakthrough infection resulted in a marked increase in the breadth and affinity of a highly abundant vaccination-elicited plasma IgG antibody, SC27. With an intrinsic binding affinity surpassing a theoretical maximum (KD &lt; 5 pM), SC27 demonstrated potent neutralization of various SARS-CoV-2 variants and SARS-like zoonotic viruses (IC50 [~]0.1-1.75 nM) and provided robust protection in vivo. Cryo-EM structural analysis unveiled that SC27 binds to the RBD class 1/4 epitope, with both VH and VL significantly contributing to the binding interface. These findings suggest that exceptionally broad and potent antibodies can be prevalent in plasma and can largely dictate the nature of serological neutralization.

HIGHLIGHTS{blacksquare} Infection and vaccination elicit unique IgG antibody profiles at the molecular level
{blacksquare}Immunological imprinting varies between infection (S2/NTD) and vaccination (RBD)
{blacksquare}Hybrid immunity maintains the imprint of first infection or first vaccination
{blacksquare}Hybrid immune IgG plasma mAbs have superior neutralization potency and breadth</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.23.576505">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.23.576505" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.23.576505">
        <p class="paperTitle">CD4&#43; and CD8&#43; T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.23.576505" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.23.576505" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Kar, M.; Johnson, K. E. E.; Vanderheiden, A.; Elrod, E. J.; Floyd, K.; Geerling, E.; Stone, E. T.; Salinas, E.; Banakis, S.; Wang, W.; Sathish, S.; Shrihari, S.; Davis-Gardner, M. E.; Kohlmeier, J.; Pinto, A.; Klein, R.; Grakoui, A.; Ghedin, E.; Suthar, M. S.</p>
        <p class="info">Score: 66.9, Published: 2024-01-24 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.23.576505' target='https://doi.org/10.1101/2024.01.23.576505'> 10.1101/2024.01.23.576505</a></p>
        <p class="abstract">SARS-CoV-2 is the causative agent of COVID-19 and continues to pose a significant public health threat throughout the world. Following SARS-CoV-2 infection, virus-specific CD4&#43; and CD8&#43; T cells are rapidly generated to form effector and memory cells and persist in the blood for several months. However, the contribution of T cells in controlling SARS-CoV-2 infection within the respiratory tract are not well understood. Using C57BL/6 mice infected with a naturally occurring SARS-CoV-2 variant (B.1.351), we evaluated the role of T cells in the upper and lower respiratory tract. Following infection, SARS-CoV-2-specific CD4&#43; and CD8&#43; T cells are recruited to the respiratory tract and a vast proportion secrete the cytotoxic molecule Granzyme B. Using antibodies to deplete T cells prior to infection, we found that CD4&#43; and CD8&#43; T cells play distinct roles in the upper and lower respiratory tract. In the lungs, T cells play a minimal role in viral control with viral clearance occurring in the absence of both CD4&#43; and CD8&#43; T cells through 28 days post-infection. In the nasal compartment, depletion of both CD4&#43; and CD8&#43; T cells, but not individually, results in persistent and culturable virus replicating in the nasal compartment through 28 days post-infection. Using in situ hybridization, we found that SARS-CoV-2 infection persisted in the nasal epithelial layer of tandem CD4&#43; and CD8&#43; T cell-depleted mice. Sequence analysis of virus isolates from persistently infected mice revealed mutations spanning across the genome, including a deletion in ORF6. Overall, our findings highlight the importance of T cells in controlling virus replication within the respiratory tract during SARS-CoV-2 infection.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.24.576713">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.24.576713" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.24.576713">
        <p class="paperTitle">Development of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune Diseases</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.24.576713" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.24.576713" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Anaya, D.; Kwong, B.; Park, S.; Biswas, S.; Jeevan, J.; Strobach, M.; Khoshnoodi, N.; Register, A.; Klasson, T.; Foos-Russ, S.; Zeng, J.; Banuelos, J.; Gibson, C.; Bravo, J.; Flandez, J.; Van Blarcom, T.; Walker, K.</p>
        <p class="info">Score: 57.4, Published: 2024-01-24 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.24.576713' target='https://doi.org/10.1101/2024.01.24.576713'> 10.1101/2024.01.24.576713</a></p>
        <p class="abstract">Apheresis, a conventional starting point for manufacturing chimeric antigen receptor (CAR) T-cell therapy, poses challenges due to the length and invasiveness of the procedure, the high demand for and limited quantity of apheresis beds, and additional resource constraints at collection centers. Furthermore, traditional CAR T-cell manufacturing often involves extended cell culture periods, leading to a final product that has progressed through the differentiation process and contains a higher frequency of cells with phenotypes that are indicative of lower functionality or potency.1 Here, we show that anti-CD19 CAR T-cells manufactured from fresh whole blood with minimal ex vivo expansion using Ingenui-T exhibit comparable or superior CAR-mediated and CD19-dependent functional activity compared to CAR T-cells manufactured from cryopreserved leukapheresis material following the a conventional manufacturing process. Anti-CD19 CAR T-cell production, manufactured from whole blood in less than 3 days of in vitro culture using Ingenui-T, yielded an average of about 40 million cells per 100 mL with high CD3 purity and viability. Furthermore, the final product was composed of cells with less differentiated phenotypes and sustained cytotoxic activity against CD19&#43; target cells at a lower dose than conventionally manufactured CAR T cells in preclinical in vitro assays. Ingenui-T is an innovative vein-to-vein solution, aimed at enhancing the patient experience, feasibility, and accessibility of CAR T-cell therapy by alleviating challenges linked to apheresis-based methods, with its patient-friendly nature, cost-effectiveness, and distinctive methodology.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.20.576452">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.20.576452" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.20.576452">
        <p class="paperTitle">Full resolution HLA and KIR genes annotation for human genome assemblies</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.20.576452" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.20.576452" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Zhou, Y.; Song, L.; Li, H.</p>
        <p class="info">Score: 42.7, Published: 2024-01-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.20.576452' target='https://doi.org/10.1101/2024.01.20.576452'> 10.1101/2024.01.20.576452</a></p>
        <p class="abstract">The HLA (Human Leukocyte Antigen) genes and the KIR (Killer cell Immunoglobulin-like Receptor) genes are critical to immune responses and are associated with many immune-related diseases. Located in highly polymorphic regions, they are hard to be studied with traditional short-read alignment-based methods. Although modern long-read assemblers can often assemble these genes, using existing tools to annotate HLA and KIR genes in these assemblies remains a non-trivial task. Here, we describe Immuannot, a new computation tool to annotate the gene structures of HLA and KIR genes and to type the allele of each gene. Applying Immuannot to 56 regional and 212 whole-genome assemblies from previous studies, we annotated 9,931 HLA and KIR genes and found that almost half of these genes, 4,068, had novel sequences compared to the current Immuno Polymorphism Database (IPD). These novel gene sequences were represented by 2,664 distinct alleles, some of which contained non-synonymous variations resulting in 92 novel protein sequences. We demonstrated the complex haplotype structures at the two loci and reported the linkage between HLA/KIR haplotypes and gene alleles. We anticipate that Immuannot will speed up the discovery of new HLA/KIR alleles and enable the association of HLA/KIR haplotype structures with clinical outcomes in the future.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.26.577360">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.26.577360" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.26.577360">
        <p class="paperTitle">Cytotoxic CD4&#43; T cells in the bone marrow compromise healthy ageing by enhancing granulopoiesis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.26.577360" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.26.577360" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Gabande-Rodriguez, E.; Soto-Heredero, G.; Carrasco, E.; Anerillas, C.; Escrig-Larena, J. I.; Delgado-Pulido, S.; Francos-Quijorna, I.; Gomez de las Heras, M. M.; Fernandez-Almeida, A.; Blanco, E. M.; Winand-Osete, E.; Zorita, V.; Martinez-Cano, J.; Garrido, A.; de Cabo, R.; Manes, S.; Gorospe, M.; Mittelbrunn, M.</p>
        <p class="info">Score: 34.7, Published: 2024-01-29 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.26.577360' target='https://doi.org/10.1101/2024.01.26.577360'> 10.1101/2024.01.26.577360</a></p>
        <p class="abstract">Neutrophils are the most abundant leukocytes in the blood, with numbers further increasing with age. Despite their essential role as a primary line of defense, neutrophils can contribute to tissue damage and age-related diseases and a high neutrophil-to lymphocyte ratio predicts all causes of mortality in the elderly. However, the precise mechanisms driving enhanced neutrophil generation during ageing remain poorly understood. Here, we show that a subset of CD4&#43; T cells with a cytotoxic phenotype (CD4&#43; CTLs) producing the chemokine CCL5 and harbouring dysfunctional mitochondria, infiltrate the bone marrow and induce granulopoiesis in aged mice. During ageing, hematopoietic stem cells upregulate CCR5, the primary receptor for CCL5, and its deficiency limits the T cell-mediated induction of granulopoiesis and neutrophil output. Treatment with the FDA-approved CCR5 inhibitor Maraviroc decreases granulopoiesis and lowers the levels of circulatory and tissue-infiltrating neutrophils, ameliorating multiple ageing biomarkers and improving functional outcomes in aged mice. These findings suggest that age-associated alterations in T cells reduce health outcomes by remodelling the bone marrow niche and enhancing neutrophil generation. Consequently, interventions to disrupt the interplay between T cells and haematopoietic stem cells hold substantial therapeutic potential to ameliorate age-associated diseases.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.14.575313">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.14.575313" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.14.575313">
        <p class="paperTitle">CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.14.575313" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.14.575313" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Elyahu, Y.; Feygin, I.; Pinkas, N.; Zemer, A.; Shicht, A.; Berner, O.; Eremenko, E.; Nemirovsky, A.; Reshef, K.; Roitman, L.; Krizhanovsky, V.; Monsonego, A.</p>
        <p class="info">Score: 22.2, Published: 2024-01-15 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.14.575313' target='https://doi.org/10.1101/2024.01.14.575313'> 10.1101/2024.01.14.575313</a></p>
        <p class="abstract">Aging is characterized by the progressive deterioration of tissue structure and function, leading to increased vulnerability to diseases and, eventually, death. One prominent process in aging is the accumulation of senescent cells. Although the immune system has been recognized as crucial for the elimination of senescent cells, the associated mechanisms remain incompletely understood. Here we show that CD4 T cells differentiate into cytotoxic T lymphocytes (CTLs) in a senescent cell-rich environment and that a reduction in the senescent cell load, achieved using chemical senolytic drugs, was sufficient to halt this differentiation. We further demonstrate that eliminating CD4 CTLs in the context of late aging by selectively deleting the Eomes transcription factor in CD4 T cells resulted in the increased accumulation of senescent cells, profound physical deterioration, and a decreased life span. In liver cirrhosis, a model of localized chronic inflammation, CD4 CTL elimination increased the senescent load and worsened the disease. Collectively, our findings demonstrate the fundamental role of CD4 CTLs in modulating tissue senescence and unveil a new aspect of age-related T-cell biology implicated in disease susceptibility and longevity.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.24.577048">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.24.577048" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.24.577048">
        <p class="paperTitle">Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.24.577048" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.24.577048" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Costa-Pereira, S.; Lanzinger, M.; Andreadou, M.; Nunez, N.; Villar-Vesga, J.; Prisco, F.; Hane, P.; Roussel, E.; Krishnarajah, S.; Lindemann, R. C.; Westermann, F.; Oberbichler, L.; Sethi, A.; Fonseca, A.; Pinzger, M.; Tugues, S.; Mundt, S.; Kipar, A.; Greter, M.; De Feo, D.; Becher, B.</p>
        <p class="info">Score: 14.9, Published: 2024-01-27 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.24.577048' target='https://doi.org/10.1101/2024.01.24.577048'> 10.1101/2024.01.24.577048</a></p>
        <p class="abstract">Regulatory T (Treg) cells are critical for maintaining peripheral tolerance and preventing autoimmunity. Treg cell depletion or dysfunction rapidly results in fatal multiorgan inflammation linked to unrestrained effector T cell expansion, but the cytokine network underlying immunopathology, and its direct cellular mediators, remain elusive. Here, we combined gene targeting, fate-mapping tools, and high-dimensional cytometry to identify the T helper (TH) cell-derived cytokines and responding cells that execute inflammatory tissue damage upon global loss of peripheral tolerance in mice. We found that TH cell-derived GM-CSF, but not IL-17A, directed the ensuing immunopathology and thereby mortality through recruitment of tissue-invading phagocytes and granulocytes, and enhancement of their reactive oxygen species production and phagocytic proficiency. Our study highlights the critical role of Treg cells in controlling GM-CSF- producing TH cells and type 1-responses to restrain phagocyte-mediated tissue destruction and provides a framework for the use of anti-GM-CSF therapies in patients with chronic inflammatory disorders.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.25.577228">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.25.577228" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.25.577228">
        <p class="paperTitle">Learning predictive signatures of HLA type from T-cell repertoires</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.25.577228" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.25.577228" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Ortega, M. R.; Pogorelyy, M.; Minervina, A.; Thomas, P.; Walczak, A.; Mora, T.</p>
        <p class="info">Score: 12.9, Published: 2024-01-29 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.25.577228' target='https://doi.org/10.1101/2024.01.25.577228'> 10.1101/2024.01.25.577228</a></p>
        <p class="abstract">T cells recognize a wide range of pathogens using surface receptors that interact directly with peptides presented on major histocompatibility complexes (MHC) encoded by the HLA loci in humans. Understanding the association between T cell receptors (TCR) and HLA alleles is an important step towards predicting TCR-antigen specificity from sequences. Here we analyze the TCR alpha and beta repertoires of large cohorts of HLA-typed donors to systematically infer such associations, by looking for overrepresentation of TCRs in individuals with a common allele.TCRs, associated with a specific HLA allele, exhibit sequence similarities that suggest prior antigen exposure. Immune repertoire sequencing has produced large numbers of datasets, however the HLA type of the corresponding donors is rarely available. Using our TCR-HLA associations, we trained a computational model to predict the HLA type of individuals from their TCR repertoire alone. We propose an iterative procedure to refine this model by using data from large cohorts of untyped individuals, by recursively typing them using the model itself. The resulting model shows good predictive performance, even for relatively rare HLA alleles.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.23.576878">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.23.576878" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.23.576878">
        <p class="paperTitle">Integrative single-cell multi-omics of CD19CARpos and CARneg T cells suggest drivers of immunotherapy response in B-cell neoplasias</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.23.576878" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.23.576878" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Guerrero-Murillo, M.; Rill-Hinarejos, A.; Trincado, J. L.; Bataller, A.; Ortiz-Maldonado, V.; Benitez-Ribas, D.; Espanol, M.; Gonzalez, E. A.; Martinez-Cibrian, N.; Marchese, D.; Martin-Martin, L.; Garcia-Sancho, A. M.; Heyn, H.; Juan, M.; Urbano-Ispizua, A.; Delgado, J.; Orfao, A.; Mereu, E.; Bueno, C.; Menendez, P.</p>
        <p class="info">Score: 10.6, Published: 2024-01-26 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.23.576878' target='https://doi.org/10.1101/2024.01.23.576878'> 10.1101/2024.01.23.576878</a></p>
        <p class="abstract">How phenotypic, clonal, and functional heterogeneity of CAR-T-cells impact clinical outcomes remain understudied. Here, we integrated clonal kinetics with transcriptomic heterogeneity resolved by single-cell omics to explore cellular dynamics response of both non-transduced (CARneg) and transduced (CARpos)T-cells. CARneg and CARposT-cells were longitudinally interrogated in the manufactured infusion product (IP) and in-vivo at CAR-T cell expansion peak in five B-ALL patients treated with CD19CAR-T-cells (varni-cel). Significant differences were found in the cellular dynamics between CARpos and CARnegT-cells in response to therapy. CARposT-cells in the IP exhibited a significant higher CD4:CD8 ratio than CARnegT-cells, and the CD4:CD8 CARposT-cell composition impacted therapy outcome as confirmed in a larger cohort of 24 varni-cel-treated B-ALL patients. Conversely, an inverted trend in the CD4:CD8 CARposT-cell ratio was consistently observed at the expansion peak, with clonally expanding CD8&#43; effector memory and cytotoxic T-cells being the most abundant populations. Expanded cytotoxic CARpos{gamma}{delta}T cells emerged at the expansion peak, and the extent of their in-vivo expansion positively correlated with treatment efficacy, which was validated in a large cohort of B-ALL patients (n=18) treated with varni-cell and B-cell lymphoma patients (n=58) treated with either lisa-cel or axi-cel. Our data provide insights into the complexity and diversity of T-cell responses following CAR-T cell therapy and suggest drivers of immunotherapy response.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
         Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
